Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gp96 (3 trials)
autologous gp96 vaccination (2 trials)
gimeracil (1 trial)
oteracil (1 trial)
oxaliplatin (eloxatin) (1 trial)
s-1 (1 trial)
tegafur (1 trial)
temozolomide (temodar) (1 trial)
Adenocarcinoma (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Liver Neoplasms (Phase 3)
Stomach Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (8 total)